INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 178 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,716,928 | -34.8% | 570,492 | -20.8% | 0.04% | -32.3% |
| Q2 2023 | $45,584,765 | -11.0% | 719,911 | -23.9% | 0.06% | -14.5% |
| Q1 2023 | $51,225,088 | +12.0% | 945,985 | +9.5% | 0.08% | +4.1% |
| Q4 2022 | $45,720,816 | +12.0% | 863,961 | -1.5% | 0.07% | +7.4% |
| Q3 2022 | $40,832,000 | -16.7% | 877,537 | +4.4% | 0.07% | -9.3% |
| Q2 2022 | $49,010,000 | -17.4% | 840,516 | -14.6% | 0.08% | -3.8% |
| Q1 2022 | $59,350,000 | -3.9% | 983,913 | -16.6% | 0.08% | -3.7% |
| Q4 2021 | $61,753,000 | +44.1% | 1,179,839 | +2.7% | 0.08% | +22.7% |
| Q3 2021 | $42,847,000 | -19.6% | 1,149,341 | -11.9% | 0.07% | -1.5% |
| Q2 2021 | $53,278,000 | +18.7% | 1,305,190 | -1.3% | 0.07% | +15.5% |
| Q1 2021 | $44,889,000 | -46.2% | 1,322,996 | -49.6% | 0.06% | -1.7% |
| Q4 2020 | $83,508,000 | +250.8% | 2,626,052 | +162.6% | 0.06% | +55.3% |
| Q3 2020 | $23,808,000 | -17.2% | 999,897 | -10.7% | 0.04% | -26.9% |
| Q2 2020 | $28,739,000 | +66.1% | 1,119,542 | +0.2% | 0.05% | +40.5% |
| Q1 2020 | $17,304,000 | -33.0% | 1,117,833 | +48.5% | 0.04% | -11.9% |
| Q4 2019 | $25,832,000 | +141.1% | 752,895 | -47.3% | 0.04% | +121.1% |
| Q3 2019 | $10,714,000 | -42.3% | 1,428,551 | -0.1% | 0.02% | -44.1% |
| Q2 2019 | $18,567,000 | +12.5% | 1,430,469 | +5.6% | 0.03% | +17.2% |
| Q1 2019 | $16,500,000 | +25.2% | 1,354,712 | +17.1% | 0.03% | +20.8% |
| Q4 2018 | $13,182,000 | -49.4% | 1,157,356 | -3.6% | 0.02% | -46.7% |
| Q3 2018 | $26,060,000 | +22.8% | 1,200,906 | +0.6% | 0.04% | +21.6% |
| Q2 2018 | $21,222,000 | – | 1,193,594 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |